AI處方合規性自動審核工具

首頁

AI 提示詞列表

醫療健康

處方審核助手

${:__('collect %s',處方審核助手)}$

醫療健康

利用AI技術輔助藥師進行處方前置審核，識別潛在的藥物相互作用、劑量異常及禁忌症，提升用藥安全與效率。

提示內容

複製

Act as a senior clinical pharmacist to review the following electronic prescription: The patient is a 65-year-old male diagnosed with Stage 2 hypertension and mild renal impairment (eGFR 45ml/min). Current medications include Amlodipine 5mg qd, Aspirin 100mg qd, and a newly prescribed Ibuprofen 400mg tid. Analyze if this prescription contains drug-disease contraindications, drug-drug interactions, or requires dosage adjustments, and provide specific adjustment suggestions with references, ensuring the output aligns with clinical guidelines and uses natural language.

複製

請扮演資深臨床藥師，對以下電子處方進行合規性審查：患者為65歲男性，診斷為高血壓2級伴輕度腎功能不全（eGFR 45ml/min），當前用藥包括氨氯地平5mg qd、阿斯匹林100mg qd及新開具的布洛芬400mg tid。請分析該處方中是否存在藥物-疾病禁忌、藥物-藥物相互作用或劑量調整需求，並給出具體的調整建議及依據，確保輸出內容符合臨床用藥指南且語言自然流暢。

複製

分享點擊複製鏈接

評論 (0)

0/300

提交

推薦

處方審核助手

Act as a clinical pharmacist and review the prescribed medication list against the patient's electronic health records, including medical history, allergies, current medications, and lab results. Focus on analyzing potential drug-drug interactions, checking if dosages exceed safety limits, identifying incompatibilities, and verifying compliance with specific physiological conditions such as renal impairment or pregnancy. Output a detailed audit report highlighting any identified risks and provide evidence-based alternative suggestions or dosage adjustments to ensure medication safety.

處方審核助手

Act as a senior clinical pharmacist and review the following prescription data based on the latest clinical medication guidelines: Patient is 65 years old, diagnosed with type 2 diabetes and mild renal impairment (eGFR 45ml/min), currently taking metformin 1000mg bid, glimepiride 2mg qd, and aspirin 100mg qd. Focus on evaluating the risk of metformin use in renal impairment, the hypoglycemia risk of glimepiride, and potential interactions between aspirin and antidiabetic drugs, providing adjustment suggestions or contraindication warnings to ensure medication safety.

處方審核助手

Act as a senior clinical pharmacist to review the provided patient prescription. Focus on analyzing drug interactions, contraindications, and dosage appropriateness. Reference the latest clinical guidelines to highlight potential risks and provide adjustment suggestions, finally outputting a structured, professional audit report.

術後復健助手

Based on the patient's vital signs, wound healing grade, and pain scores on post-operative day 3, combined with standard orthopedic rehabilitation guidelines, please generate a concise and easy-to-understand recovery progress assessment report. The report should include the current recovery stage judgment, potential risk warnings, and key home care suggestions for the next week. The language should be gentle and professional, avoiding complex medical jargon to ensure patient comprehension and compliance.

處方審核助手

Act as a senior clinical pharmacist to review the provided patient prescription. First, extract patient demographics, diagnosis, and all prescribed drug names and dosages. Second, based on the latest clinical guidelines and package inserts, check for contraindications, drug-drug interactions, or dosage errors. Finally, if potential risks are identified, specify the conflict and provide evidence-based alternatives or adjustments; otherwise, confirm the prescription's appropriateness and output a standard compliance conclusion.

處方審核助手

Act as a clinical pharmacist and review the provided physician's prescription against the patient's electronic health records, including medical history, allergies, current medications, and lab results. Focus on analyzing drug-drug interactions, dosage appropriateness, compatibility issues, and adherence to specific physiological conditions such as renal impairment or pregnancy. Identify all potential risks and provide evidence-based modification suggestions according to clinical guidelines, then output a clear, professional audit report ensuring medication safety.